How Can Proteomics Track Therapeutic Response in Real Time?
How can proteomics help researchers track how well a therapy is working in real time? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores how protein biomarkers can provide a dynamic view of disease activity and therapeutic response.
Using Alzheimer’s disease and the circulating biomarker P-Tau 217 as an example, Gary explains how proteomics may help researchers detect disease-related changes before symptoms appear and evaluate whether a therapy is producing the desired biological effect. Monitoring protein levels can also help identify treatment responders and assess efficacy without waiting for clinical symptoms or significant disease progression.
Have a Question?
Your privacy is important to us.
We’ll never share your information.